Skip to main content
FDA Shortage Check

Is Vyvanse (Lisdexamfetamine Dimesylate Tablet, Chewable) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Vyvanse: in shortage (FDA, Oct 24)

Chewable tablets
A generic chewable tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
DRUG
Vyvanse
FDA LISTING
FORM
chewables
STATUS
Currently in Shortage
FIRST POSTED
Jul 14, 2023
LAST FDA UPDATE
Oct 19, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 18 presentations: 0 unavailable · 0 limited · 18 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Lisdexamfetamine Dimesylate Tablet, Chewable. 18 presentations from 3 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Novadoz Pharmaceuticals LLC6 presentations · 6 available or not stated

Contact (FDA's listing): (855) 668-2369; customerservice@novadozpharma.com

  • 10 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)

    NDC 72205-132-91Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)

    NDC 72205-133-91Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)

    NDC 72205-134-91Reverified

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)

    NDC 72205-135-91Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)

    NDC 72205-136-91Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)

    NDC 72205-137-91Reverified

    Available

Sun Pharmaceutical Industries, Inc.6 presentations · 6 available or not stated

Contact (FDA's listing): 800-818-4555

  • 10 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)

    NDC 57664-083-88Reverified

    Available

  • 20 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)

    NDC 57664-084-88Reverified

    Available

  • 30 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)

    NDC 57664-085-88Revised

    Available

  • 40 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)

    NDC 57664-086-88Reverified

    Available

  • 50 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)

    NDC 57664-087-88Reverified

    Available

  • 60 mg

    Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)

    NDC 57664-088-88Reverified

    Available

Takeda Pharmaceuticals USA Inc.6 presentations · 6 available or not stated

Contact (FDA's listing): 877-TAKEDA-7 (1-877-825-3327)

  • 10 mg

    Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)

    NDC 59417-115-01Reverified

    Available

  • 20 mg

    Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)

    NDC 59417-116-01Reverified

    Available

  • 30 mg

    Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)

    NDC 59417-117-01Reverified

    Available

  • 40 mg

    Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)

    NDC 59417-118-01Reverified

    Available

  • 50 mg

    Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)

    NDC 59417-119-01Reverified

    Available

  • 60 mg

    Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)

    NDC 59417-120-01Reverified

    Available

What the manufacturers told FDA

No recovery estimate posted by the makers.

More on FDA ↗ (opens in a new tab)

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Vyvanse in shortage?
Yes. As of Oct 24, 2026, FDA lists Lisdexamfetamine Dimesylate Tablet, Chewable as currently in shortage: 18 presentations, 0 unavailable and 0 limited.
When will the Vyvanse shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Vyvanse?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.